Charcot-Marie-Tooth disease type 2T (CMT2T) is a very rare inherited nerve disease that affects the peripheral nerves, which carry signals between the spinal cord and the muscles and skin. It belongs to the “type 2” or axonal group of Charcot-Marie-Tooth (CMT) disorders, meaning the main damage happens to the long nerve fibers (axons), not to the myelin coating. In most patients, CMT2T is caused by harmful changes (pathogenic variants) in both copies of the MME gene on chromosome 3q25, which encodes the enzyme membrane metalloendopeptidase (also called neutral endopeptidase or CD10). The disease usually starts in mid-adulthood with slowly progressive weakness and wasting of the muscles in the feet and lower legs, followed later by hand weakness and sensory loss.Wiley Online Library+3NCBI+3Disease Ontology+3
Charcot-Marie-Tooth disease type 2T (CMT2T) is a rare inherited nerve disease where the long nerves in the arms and legs slowly become damaged. It belongs to the “axonal” group of CMT, meaning the main problem is in the nerve fiber itself, not only in the myelin covering. People usually develop weakness and wasting in the lower legs and feet first, leading to foot drop, high-arched feet and balance problems; later the hands can also be involved. Wikipedia+1
CMT2T is caused by harmful changes (mutations) in certain genes that help nerves stay healthy, such as MME or DNAJB2 in some reported families. These gene changes are passed down in families in a dominant or recessive pattern, so other relatives may also be affected. Because the problem is genetic, there is currently no cure and no disease-modifying drug approved specifically for CMT2T. Treatment focuses on keeping you mobile, reducing pain, preventing complications, and protecting quality of life with physical therapy, bracing, surgery when needed, and medicines for symptoms. FlyBase+2ScienceDirect+2
CMT2T causes a length-dependent sensorimotor polyneuropathy. This means the longest nerves, which go to the feet, are affected first and most, so patients notice foot drop, tripping, and numbness in the toes early in the disease. Reflexes, especially at the ankles, become reduced or lost. Over many years the weakness and numbness may spread upward in the legs and later into the hands, but the course is usually slowly progressive.NCBI+2Europe PMC+2
Although CMT2T is defined by MME variants, some databases and laboratories also link the code “CMT2T” to DNAJB2-related axonal neuropathies, because these conditions share similar patterns of progressive motor and sensory nerve damage. DNAJB2 is a heat-shock protein (Hsp40) chaperone expressed in neurons. In practice, doctors focus on the clinical picture (slowly progressive axonal neuropathy) and confirm the exact gene by genetic testing.ClinGen+4PMC+4Orpha.net+4
Other names
CMT2T has several other names in medical databases and research papers. These names all describe the same or closely overlapping disease concept.Yeast Genome Database+3National Organization for Rare Disorders+3NCBI+3
One common name is “Charcot-Marie-Tooth disease, axonal, type 2T”, which emphasises that this is an axonal form of CMT (type 2) and that 2T is a specific letter code within this group. This label is used in the NIH Genetic Testing Registry and OMIM.NCBI+1
Another widely used term is “Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2T (AR-CMT2T)”. This name highlights that in many families both copies of the MME gene must be changed (autosomal recessive inheritance) before the disease appears.Disease Ontology+2FlyBase+2
Some resources describe it as “MME-related Charcot-Marie-Tooth disease type 2” or “MME-related CMT2”, to make clear that the underlying cause is a variant in the MME gene and to distinguish it from CMT2 caused by other genes such as MFN2 or GARS1.Muscular Dystrophy Association+3Genetic Rare Diseases Center+3Orpha.net+3
You may also see the shorthand “AR-CMT2T” or simply “CMT2T” in genetic reports, and some gene and variant databases list DNAJB2 with “CMT2T” as an alias because DNAJB2-related axonal neuropathies overlap clinically with MME-related CMT2T.ClinGen+3Orpha.net+3Global Genes+3
Types (clinical patterns)
Doctors usually describe clinical sub-types or patterns inside CMT2T instead of formal new codes. These patterns are based on inheritance, age at onset, and symptoms.Muscular Dystrophy Association+4NCBI+4IJCRIOG+4
Autosomal recessive CMT2T – This is the classic and most clearly defined pattern. The patient has two pathogenic variants in MME (homozygous or compound heterozygous), and the disease appears in mid-adulthood with slowly progressive sensorimotor axonal neuropathy.Disease Ontology+2FlyBase+2
Autosomal dominant MME-related CMT2 – Some families have a single pathogenic MME variant and show a late-onset, often milder polyneuropathy. These cases may be labelled “MME-related autosomal dominant CMT2” and are closely related to, but not always coded exactly as, CMT2T in older systems.MalaCards+3Genetic Rare Diseases Center+3Orpha.net+3
Typical sensorimotor CMT2T – In this pattern both motor and sensory nerves are affected. Patients have weakness, wasting, and also numbness, tingling, and reduced vibration sense in a length-dependent pattern. This is the most common clinical picture.Muscular Dystrophy Association+3NCBI+3Disease Ontology+3
Predominantly motor CMT2-like pattern – Some patients with MME or DNAJB2 variants have mainly motor symptoms at first (distal hereditary motor neuropathy picture) with only mild or late sensory loss. Over time, sensory involvement may appear.MalaCards+3PMC+3PubMed+3
Middle-age onset CMT2T – Many patients first notice symptoms such as tripping and distal weakness between about 36 and 56 years of age, which is typical for CMT2T linked to MME.NCBI+2MalaCards+2
Late-onset MME neuropathy – In some autosomal dominant MME-related cases, symptoms may begin later in life (for example after the age of 60), when age-related nerve vulnerability adds to the effect of the variant.Orpha.net+2IJCRIOG+2
These “types” are practical groupings that help doctors understand and explain how the same underlying gene defect can present in slightly different ways in different families.Europe PMC+1
Causes
In strict medical terms, the only proven root cause of CMT2T is a harmful change in the MME gene. The other items listed below are contributing mechanisms, inheritance patterns, or additional factors that modify how and when the disease shows, or they are alternative acquired causes of neuropathy that must be ruled out.NCBI+3Disease Ontology+3FlyBase+3
Pathogenic variants in the MME gene – CMT2T occurs when the MME gene contains disease-causing variants that change or remove the function of the neutral endopeptidase enzyme, leading to progressive axonal damage in peripheral nerves.Disease Ontology+2FlyBase+2
Homozygous MME variants – Many patients have the same variant in both copies of the MME gene (one from each parent). This homozygosity is a classic autosomal recessive cause of CMT2T and explains why the disease may appear in siblings but not in parents.Disease Ontology+2FlyBase+2
Compound heterozygous MME variants – Some patients inherit two different disease-causing variants in MME. Together these two faulty copies still lead to lack of normal enzyme function and to CMT2T.Disease Ontology+2FlyBase+2
Autosomal dominant MME variants – In certain families, a single heterozygous pathogenic MME variant is enough to cause a late-onset axonal neuropathy, giving an autosomal dominant pattern that overlaps with CMT2T.MalaCards+3Genetic Rare Diseases Center+3Orpha.net+3
Loss of neutral endopeptidase activity – MME encodes neutral endopeptidase, which helps break down several neuropeptides. When this enzyme is reduced or absent because of variants, neuropeptide balance in peripheral nerves is disturbed, contributing to axonal damage.IJCRIOG+2Wiley Online Library+2
Chronic axonal degeneration in long nerves – Axons in the longest nerves (to the feet and hands) are especially sensitive to disturbed peptide signalling and metabolic stress from MME dysfunction, so they slowly degenerate over years and cause the characteristic length-dependent neuropathy.Europe PMC+2Muscular Dystrophy Association+2
Length-dependent vulnerability of peripheral nerves – Because distal axons are far from the nerve cell body, any loss of trophic support or metabolic handling caused by MME variants tends to show first at the nerve endings in the feet and later in the hands.Europe PMC+2Muscular Dystrophy Association+2
Autosomal recessive inheritance from carrier parents – In classic CMT2T, each parent carries one faulty MME gene but usually has no symptoms. When a child inherits both faulty copies, CMT2T develops. This inheritance pattern explains why the disease can repeat in siblings.Disease Ontology+2FlyBase+2
Autosomal dominant inheritance in some MME families – Rarely, one pathogenic MME variant is enough to cause neuropathy, so each child of an affected parent has a 50% chance of inheriting the variant and being affected.Genetic Rare Diseases Center+2Orpha.net+2
Family history and consanguinity – Having relatives with CMT or marrying within a small or related community increases the chance that both parents carry the same recessive MME variant, which raises the risk of CMT2T in their children.Disease Ontology+2FlyBase+2
Age-related accumulation of nerve damage – Many patients develop symptoms in mid-life or later, suggesting that time and normal ageing add to the genetic vulnerability and allow axonal damage to build up enough to cause noticeable weakness and sensory loss.NCBI+2IJCRIOG+2
Co-existing diabetes – Diabetes does not cause CMT2T, but if a person with an MME variant also develops diabetic neuropathy, the combined effect can make symptoms appear earlier or progress faster, and it complicates diagnosis.IJCRIOG+2IJCaseReports and Images+2
Vitamin B12 or folate deficiency – Low levels of these vitamins damage peripheral nerves. In a person with underlying CMT2T, such deficiencies can worsen numbness, imbalance, and weakness, so they are important to detect and treat.IJCRIOG+2NCBI+2
Neurotoxic medications (for example, some chemotherapy drugs) – Certain drugs are known to injure peripheral nerves. If these are given to someone with MME-related CMT, the neuropathy may become more severe or progress more quickly.IJCRIOG+2NCBI+2
Chronic alcohol misuse – Long-term heavy alcohol use can cause an acquired axonal polyneuropathy. In an individual who already has inherited CMT2T, alcohol-related nerve damage can strongly increase disability.IJCRIOG+2NCBI+2
Superimposed nerve compression – Entrapment neuropathies such as carpal tunnel syndrome or peroneal nerve compression at the fibular head can occur on top of CMT2T, adding focal weakness and numbness to the existing diffuse neuropathy.NCBI+1
Uncontrolled thyroid disease – Both hypothyroidism and hyperthyroidism can affect peripheral nerves. In a person with CMT2T, such endocrine problems can worsen fatigue, cramps, and sensory symptoms until they are corrected.IJCRIOG+2NCBI+2
Autoimmune neuropathies occurring in the same patient – Conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP) can rarely coexist with hereditary neuropathy. If this happens in CMT2T, nerve function may decline more rapidly but may partially improve with immune treatment.NCBI+1
Infections that affect nerves – Severe infections or post-infectious inflammatory neuropathies can temporarily worsen walking and strength in a person with CMT2T and may mislead doctors unless the underlying hereditary disease is recognised.IJCRIOG+2NCBI+2
Lack of early diagnosis and rehabilitation – Not recognising CMT2T early does not cause the genetic disease, but it means that supportive care, physiotherapy, and orthotic devices are delayed, so secondary problems such as joint contractures, deformities, and falls become more severe than they need to be.NCBI+2Muscular Dystrophy Association+2
Symptoms
Not every person with CMT2T will have all of these symptoms, but the list below summarises the most common and important clinical features seen across reported patients with MME-related and closely related axonal CMT2 phenotypes.Muscular Dystrophy Association+3NCBI+3Orpha.net+3
Slowly progressive weakness in the feet and ankles – The first sign is often trouble lifting the front of the foot (foot drop), difficulty climbing stairs, or frequent tripping because the ankle muscles are weak.NCBI+2Orpha.net+2
Foot drop and high-stepping gait – To clear the toes from the floor, patients may lift their knees higher than normal when walking, giving a high-stepping gait, especially noticeable on uneven ground or when tired.Orpha.net+2Muscular Dystrophy Association+2
Wasting of calf and foot muscles – Over time, the small muscles of the feet and the lower legs shrink, giving a “stork leg” or “inverted champagne bottle” appearance because the calves become thin compared with the thighs.Orpha.net+2Muscular Dystrophy Association+2
Weakness in the hands and fingers – As the disease progresses, the small muscles of the hands may weaken, making it hard to grip objects firmly, write for long periods, or do fine tasks such as buttoning clothes or using tools.Orpha.net+2Global Genes+2
Numbness and reduced sensation in feet and hands – Many patients notice loss of feeling for light touch, pain, temperature, or vibration in the toes and soles, later spreading to the fingers, which can lead to injuries without pain being felt.NCBI+2Orpha.net+2
Tingling, pins and needles, or burning pain – Abnormal firing of damaged sensory nerves may cause unpleasant sensations such as tingling, electric shocks, or burning pain in the feet or hands, especially at night.Orpha.net+2NCBI+2
Reduced or absent ankle reflexes – On neurological examination, the doctor often finds that ankle tendon reflexes are weak or absent, and in more advanced disease knee reflexes may also be reduced.Muscular Dystrophy Association+2NCBI+2
High-arched feet (pes cavus) and hammer toes – Long-standing muscle imbalance around the foot and ankle can cause structural deformities, including high arches and curled toes, which can make shoe fitting and walking more difficult.Muscular Dystrophy Association+2NCBI+2
Unsteady gait and poor balance – Loss of joint position sense (proprioception) and weakness together lead to poor balance. Patients may sway more when standing, especially with eyes closed, and may have difficulty walking in the dark.NCBI+2Muscular Dystrophy Association+2
Hand clumsiness and dropping objects – Because of both weakness and impaired sensation, patients may drop items, struggle with zips and buttons, and find handwriting more tiring or less controlled.Orpha.net+2Global Genes+2
Muscle cramps and twitching – Some individuals report painful cramps, especially in the calves or arches of the feet, and visible muscle twitches (fasciculations), reflecting irritability of damaged motor units.Orpha.net+2NCBI+2
Fatigue and reduced walking distance – Because the muscles are weak and the nerves work less efficiently, patients often become tired more quickly when walking, climbing, or standing for long periods, and they may need frequent rests.Orpha.net+2Muscular Dystrophy Association+2
Leg and ankle pain due to joint strain – Foot deformities and abnormal gait put extra stress on joints, ligaments, and tendons, which can cause mechanical pain around the ankles, knees, or lower back, even apart from nerve pain.NCBI+2Muscular Dystrophy Association+2
Speech or swallowing difficulty in some severe cases – In some DNAJB2-related CMT2 and related phenotypes, bulbar muscles can be affected, leading to slurred speech (dysarthria) or mild swallowing problems (dysphagia), though this is less typical for classic MME-related CMT2T.Orpha.net+2Global Genes+2
Breathing problems in advanced disease – Very rarely, late-stage involvement of respiratory muscles may cause shortness of breath, especially at night, and some patients may need non-invasive ventilatory support. This tends to occur only in more severe, advanced neuropathy.Orpha.net+2Global Genes+2
Diagnostic tests
Diagnosis of CMT2T is based on a combination of clinical assessment, electrodiagnostic studies, laboratory tests, imaging, and confirmatory genetic testing. The aim is to show that there is a chronic axonal sensorimotor neuropathy, to exclude common acquired causes, and to identify a disease-causing MME (or occasionally DNAJB2-related) variant.NCBI+4NCBI+4Europe PMC+4
Below are 20 key diagnostic tests and assessments, grouped by category but numbered in one list. Each test helps in a different way to confirm CMT2T or to rule out other conditions that can mimic it.NCBI+2Europe PMC+2
Physical exam tests
Comprehensive neurological examination – The neurologist checks muscle strength, tone, reflexes, and sensation throughout the body. In CMT2T this exam usually shows distal weakness, wasting, reduced ankle reflexes, and length-dependent sensory loss, which together point strongly toward a chronic peripheral neuropathy.NCBI+2Europe PMC+2
Gait and posture assessment – The doctor watches how the patient walks, turns, and stands. A high-stepping gait, foot slap, difficulty walking on heels, and imbalance when turning are classic signs of distal motor weakness and sensory loss in CMT2.Europe PMC+2Muscular Dystrophy Association+2
Inspection of feet and hands for deformities – Careful observation can show high arches, hammer toes, calluses, and sometimes clawing of the hands. These structural changes develop over years from chronic muscle imbalance and are typical of long-standing CMT.NCBI+2Muscular Dystrophy Association+2
Balance and coordination testing (including Romberg test) – The patient is asked to stand with feet together and then with eyes closed. Worsening sway or loss of balance with eyes closed suggests impaired proprioception from peripheral nerve damage, supporting a diagnosis of sensory neuropathy.NCBI+2Europe PMC+2
Cranial nerve and bulbar function examination – Although often normal in CMT2T, the doctor may check facial movement, tongue strength, swallowing, and speech clarity, especially when DNAJB2-related overlap is suspected, because some patients show dysarthria or mild dysphagia.Orpha.net+2Global Genes+2
Manual functional tests
Manual muscle testing with the MRC scale – The examiner grades the strength of key muscle groups (for example ankle dorsiflexion, toe extension, hand intrinsic muscles) from 0 to 5. In CMT2T, distal muscles show lower scores than proximal ones, confirming a length-dependent pattern of weakness.Europe PMC+2Muscular Dystrophy Association+2
Grip and pinch strength tests – Using a handheld dynamometer or even simple resistance, the clinician measures how hard the patient can squeeze or pinch. Reduced values, particularly compared with age-matched norms, help document hand involvement and track progression over time.Europe PMC+2ScienceDirect+2
Heel-walking and toe-walking tests – Asking the patient to walk on heels alone or toes alone is a quick bedside way to probe distal strength. Difficulty heel-walking points to weakness of ankle dorsiflexors (foot drop), while problems with toe-walking suggest calf weakness, both common in CMT2.Europe PMC+2Muscular Dystrophy Association+2
Timed 10-meter walk or 6-minute walk test – These functional tests measure how fast and how far a patient can walk safely. Slower speed, shorter distance, and need for rests or support reflect the impact of neuropathy on everyday mobility and are useful outcome measures in follow-up.Europe PMC+2ScienceDirect+2
Hand dexterity tests (such as the Nine-Hole Peg Test) – The patient is timed while placing and removing pegs from a board. Poor performance shows impaired fine motor control and coordination of the hands, which is common in advanced CMT2T and related neuropathies.Europe PMC+2ScienceDirect+2
Lab and pathological tests
Basic blood tests to exclude common acquired neuropathies – Tests such as glucose/HbA1c, vitamin B12 and folate, thyroid function, kidney and liver function, and serum protein electrophoresis are performed to rule out diabetes, vitamin deficiency, thyroid disease, and paraproteinemias, which can cause similar polyneuropathies.IJCRIOG+2NCBI+2
Serum protein electrophoresis and immunofixation – These tests look for abnormal monoclonal proteins that may indicate conditions like monoclonal gammopathy or myeloma. Finding such a protein would suggest a different or additional cause of neuropathy rather than pure hereditary CMT2T.NCBI+1
Serum creatine kinase (CK) level – CK may be normal or mildly elevated in CMT. Measuring it helps distinguish CMT2T from primary muscle disorders, which usually have much higher CK, and from some inflammatory neuropathies.NCBI+2ScienceDirect+2
Nerve biopsy (usually sural nerve) – In difficult cases, a small piece of a sensory nerve may be removed for microscopic study. In axonal CMT2, biopsy typically shows chronic axonal loss with secondary myelin changes rather than primary demyelination, supporting the diagnosis of axonal hereditary neuropathy. Because this test is invasive, it is now used less often.NCBI+2ScienceDirect+2
Genetic testing panels for neuropathy genes – Next-generation sequencing panels that include MME, DNAJB2, and many other CMT-related genes are a central part of modern diagnosis. Identifying one or two clearly pathogenic variants in MME confirms CMT2T and guides family counselling.IJCaseReports and Images+4ScienceDirect+4NCBI+4
Electrodiagnostic tests
Nerve conduction studies (NCS) – NCS measure the speed and size of electrical signals in peripheral nerves. In CMT2T they usually show reduced amplitudes of sensory and motor responses (axonal loss) with relatively preserved conduction velocities, confirming an axonal sensorimotor neuropathy typical of CMT2.Europe PMC+2NCBI+2
Electromyography (EMG) – EMG uses a fine needle electrode inside muscles to record electrical activity. In CMT2T, EMG typically shows signs of chronic denervation and reinnervation, such as large, long-duration motor unit potentials, which reflect long-standing axonal loss.Europe PMC+2ScienceDirect+2
Quantitative sensory testing (QST) – QST uses controlled mechanical or thermal stimuli to measure sensory thresholds. Abnormal vibration and temperature thresholds in a length-dependent pattern support the presence of a chronic sensory neuropathy and can help monitor progression or treatment trials.Europe PMC+2ScienceDirect+2
Imaging tests
MRI of the lumbosacral spine – Although often normal in CMT2T, spinal MRI is used to rule out structural causes of leg weakness and numbness, such as spinal stenosis or disc herniation. A normal scan in the presence of length-dependent neuropathy increases confidence that the problem is peripheral and likely hereditary.NCBI+1
Peripheral nerve imaging (nerve ultrasound or MR neurography) – High-resolution ultrasound or MRI of peripheral nerves can show nerve size and structure. In many axonal CMT2 forms, nerves are normal or only mildly enlarged, which helps distinguish them from demyelinating CMT1, where nerves are often markedly enlarged. These imaging tools are mainly supportive and research-oriented in CMT2T.ScienceDirect+2Europe PMC+2
Goals of Treatment
For CMT2T, the main treatment goals are to keep muscles and joints working as well as possible, slow down contractures and deformities, manage neuropathic pain, and prevent falls, ulcers and infections. A good care plan usually includes a neurologist, physiotherapist, occupational therapist, orthotist, podiatrist, orthopedic surgeon and sometimes a psychologist. PMC+2Vitaccess+2
Right now no medicine has FDA approval specifically for CMT2T. Drugs used are mainly taken from treatments for other neuropathic pain conditions (like diabetic neuropathy) and are used “off-label” for CMT. Surgery and experimental gene or stem-cell therapies are being studied in research, but they are not standard care for this subtype. Because you are a young person, it is very important never to start, stop or change any medicine, supplement or experimental therapy without your own doctor’s advice, and never to hide treatments from your parents or guardians. ScienceDirect+2PMC+2
Non-Pharmacological Treatments
1. Individualized physiotherapy exercise program
A structured physiotherapy program is one of the most important non-drug treatments for Charcot-Marie-Tooth disease type 2T. A physiotherapist designs gentle stretching, strengthening and coordination exercises that match your weakness pattern and balance level. Regular, supervised exercise can help keep joints flexible, slow down stiffness and maintain the muscles that still work. It also helps you learn safe ways to walk and move so you use less energy and reduce falls. nhs.uk+2PMC+2
Purpose: To maintain mobility, range of motion and muscle strength for everyday activities.
Mechanism: Repeated, low-impact movement maintains muscle fibers, improves blood flow to nerves and joints, and trains the brain and nerves to use the remaining pathways more efficiently. Physiopedia+1
2. Balance and proprioception training
Because CMT2T damages nerves that sense position and touch, many people feel unsteady and trip easily. Balance training uses simple tasks like standing on different surfaces, heel-to-toe walking or using balance boards with safety support. Over time this can improve confidence and reduce fear of falling. Physiopedia+1
Purpose: To reduce falls and injuries and make walking safer.
Mechanism: Repeated challenge to balance helps the brain use vision, remaining sensation and muscle feedback more effectively, compensating partly for damaged nerves. Pod NMD+1
3. Stretching to prevent contractures
Tight calf, hamstring and foot muscles can pull joints into fixed positions, leading to contractures and deformities like toe clawing and high arches. Daily slow stretching of ankles, knees, hips, hands and fingers helps keep joints flexible. A physiotherapist can teach safe stretches that are not painful. nhs.uk+1
Purpose: To delay or prevent fixed joint deformities and maintain comfortable movement.
Mechanism: Stretching slowly lengthens muscle-tendon units and reduces stiffness in the joint capsule, so uneven muscle pulling does less structural damage over time. PMC+1
4. Low-resistance strength training
Light strengthening with elastic bands, water exercises or very low weights can help maintain muscle power in partly weak muscles without causing over-fatigue. Exercise is usually focused on hips, thighs, core muscles and any preserved ankle or hand muscles. Physiopedia+1
Purpose: To support posture, walking and transfers like standing from a chair.
Mechanism: Low-load, repeated contractions stimulate remaining motor units and improve endurance, which helps the body compensate for lost nerve supply. PMC+1
5. Gait training with assistive devices
A physiotherapist can train you to walk more safely using walking sticks, a cane or a walker if needed. They also adjust step length, foot placement and speed to reduce tripping. Practice in different environments (indoors, outdoors, stairs) prepares you for real life. Mayo Clinic+1
Purpose: To make walking safer and more energy-efficient.
Mechanism: Guided practice rewires motor patterns in the brain and uses supports to keep the center of gravity within a safe base, reducing demands on weak muscles. Physiopedia+1
6. Ankle–foot orthoses (AFOs)
AFOs are custom braces that hold the ankle in a stable position and lift the front of the foot during walking. They are widely used in CMT to manage foot drop, high arches and ankle instability. Many people walk more smoothly and fall less when using the right AFO. Hancock Health+3Charcot-Marie-Tooth Association+3The Foundation for Peripheral Neuropathy+3
Purpose: To prevent the toes from dragging, improve step clearance and protect joints.
Mechanism: The brace mechanically supports weak muscles, transfers forces through the plastic or carbon shell, and reduces “wobble” at the ankle so nerves and muscles do not have to work as hard. Charcot-Marie-Tooth Disease+1
7. Special footwear and insoles
Custom shoes, cushioned insoles, and rocker-bottom soles help distribute pressure evenly and support high arches or other deformities. Good shoes lower the risk of calluses, ulcers and ankle sprains and may reduce pain. Mayo Clinic+2Cleveland Clinic+2
Purpose: To protect numb feet, improve comfort and support walking.
Mechanism: Extra depth and support change how forces pass through the foot, reducing pressure points and minimizing skin breakdown in areas with reduced feeling. Charcot-Marie-Tooth Disease+1
8. Occupational therapy for hand function
Occupational therapists teach exercises and strategies for weak hands, such as using thicker pens, zipper pulls, button hooks and specially designed kitchen tools. They also suggest ways to adapt school or work tasks so they are easier and safer. Mayo Clinic+1
Purpose: To keep independence in writing, typing, eating, dressing and other daily tasks.
Mechanism: Adaptive devices reduce the effort needed from small hand muscles and allow larger, stronger muscles or different movement patterns to do the same job. Physiopedia+1
9. Hand splints and wrist supports
Soft or rigid splints can support weak wrists or fingers, prevent deformity and improve grip in selected people. They are often used together with hand exercises and adaptive tools. Mayo Clinic+1
Purpose: To stabilize the hand and improve fine motor control.
Mechanism: Splints position joints in a functional alignment so the remaining muscles can work more effectively, and they reduce strain on overstretched tendons. Physiopedia+1
10. Energy conservation and fatigue management
Many people with CMT2T feel tired because walking and tasks require more effort. Therapists teach pacing (rest between tasks), planning (group tasks together), using seating, and simplifying movements. This helps you save energy for the most important activities. PMC+1
Purpose: To reduce exhaustion and improve participation in school, work and family life.
Mechanism: By balancing activity and rest, the nervous system and muscles avoid constant overload, which helps control pain and fatigue. ScienceDirect+1
11. Podiatry and regular foot care
Because feeling is decreased, small cuts and pressure areas may be missed and become infected. A podiatrist (foot specialist) trims nails safely, removes hard skin and gives advice on socks and shoes. Mayo Clinic+2The Foundation for Peripheral Neuropathy+2
Purpose: To prevent ulcers, infections and serious foot complications.
Mechanism: Regular inspection and early treatment of minor problems reduce the chance that unnoticed injuries progress to deep ulcers or bone infections. The Foundation for Peripheral Neuropathy+1
12. Fall-prevention and home safety changes
Simple changes like removing loose rugs, adding grab bars, using good lighting and organizing cables can greatly lower fall risk. An occupational therapist can do a home assessment to suggest changes. Mayo Clinic+1
Purpose: To reduce fractures, head injury and fear of movement.
Mechanism: Environmental changes remove common tripping hazards and make it easier to use walking aids safely. Mayo Clinic+1
13. Healthy-weight nutritional counselling
Extra body weight puts more strain on weak muscles and joints, which can worsen fatigue and pain. A dietitian can help build a balanced, culturally appropriate eating plan to reach or maintain a healthy weight. Mayo Clinic+2Frontiers+2
Purpose: To lessen joint stress, improve mobility and support overall health.
Mechanism: Healthy weight reduces mechanical load on feet, ankles and knees and may also improve metabolic health, which indirectly supports nerve function. PMC+1
14. Smoking cessation support
Smoking reduces blood flow and damages small blood vessels, which can further harm already fragile peripheral nerves. Quitting smoking may slow additional nerve damage and improves general health. ScienceDirect+1
Purpose: To protect nerves and the cardiovascular system.
Mechanism: Stopping tobacco allows better oxygen and nutrient delivery to nerves and muscles and reduces oxidative stress that can worsen neuropathy. MDPI+1
15. Psychological counselling and peer support
Living with a progressive genetic disease can cause sadness, anxiety, or low confidence. Talking with psychologists or joining CMT support groups helps people share coping strategies and feel less alone. PMC+1
Purpose: To support mental health and adaptation to long-term disability.
Mechanism: Counselling and peer contact build resilience, teach problem-solving and reduce stress hormones that can worsen pain perception. Mayo Clinic+1
16. School and vocational rehabilitation planning
Specialists can help plan school accommodations (extra time, typing instead of handwriting, elevator use) and advise on job choices that fit physical abilities. Genomics Education Programme+1
Purpose: To keep education and career plans realistic but hopeful.
Mechanism: Matching tasks to abilities reduces frustration and physical over-strain, helping people remain engaged in school and work. Physiopedia+1
17. Regular aerobic activity (swimming, cycling, walking)
Light aerobic exercise, like swimming, cycling or gentle walking with aids, can improve stamina and heart health without overloading weak muscles. These activities are usually chosen because they are low-impact and can be paced. nhs.uk+1
Purpose: To improve endurance, mood and cardiovascular health.
Mechanism: Aerobic activity enhances blood flow, supports mitochondrial function and can reduce inflammation, which may help nerves function better. PMC+1
18. Temperature and skin protection education
Numb feet and hands may not feel heat or cold properly, so burns or frostbite can occur. Education about safe water temperature, footwear, and avoiding walking barefoot is very important. Mayo Clinic+1
Purpose: To prevent unnoticed burns, cuts and skin damage.
Mechanism: Protective behaviours reduce exposure to harmful temperatures and mechanical trauma in areas with reduced sensation. The Foundation for Peripheral Neuropathy+1
19. Genetic counselling for families
Genetic counselling helps families understand inheritance patterns, testing options and reproductive choices. This is important because CMT2T is hereditary and can affect more than one generation. FlyBase+1
Purpose: To support informed decisions about family planning and testing.
Mechanism: Explaining risk and options (such as carrier testing or prenatal diagnosis where available) helps families prepare and reduces uncertainty. Mayo Clinic+1
20. Long-term structured follow-up in a neuromuscular clinic
Regular visits with a neuromuscular team allow early detection of new weakness, deformities, breathing issues or pain problems. The care plan can then be updated quickly. ScienceDirect+1
Purpose: To keep treatment up to date and prevent avoidable complications.
Mechanism: Ongoing monitoring and early intervention reduce the risk that small issues turn into large, disabling problems. PMC+1
Drug Treatments
Very important: No drug is currently FDA-approved specifically for Charcot-Marie-Tooth disease type 2T. The medicines below are mainly approved for other neuropathic pain conditions (like diabetic neuropathy or post-herpetic neuralgia) and are sometimes used “off-label” by neurologists to help pain and other symptoms in CMT. Doses and choices must always be individualized by a doctor, especially in teenagers. ScienceDirect+1
For FDA label information I refer to accessdata.fda.gov and summarize in simple language.
1. Gabapentin
Gabapentin is an anti-seizure medicine widely used for nerve pain such as post-herpetic neuralgia. According to its FDA label, adults often start around 300–900 mg per day in divided doses, slowly increased as needed and tolerated. FDA Access Data+1
Class: Anticonvulsant / neuropathic pain agent.
Purpose in CMT2T: To reduce burning, tingling and shooting neuropathic pain in feet and hands.
Mechanism: Gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the nervous system and lowers release of excitatory neurotransmitters, which calms overactive pain pathways. FDA Access Data+1
Common side effects: Sleepiness, dizziness, weight gain and swelling of legs; it can worsen balance in some patients, so dose must be adjusted carefully. FDA Access Data+1
2. Pregabalin
Pregabalin (brand Lyrica) is also approved for several neuropathic pain conditions, including diabetic peripheral neuropathy and post-herpetic neuralgia. Adults commonly start at about 150 mg per day split into two or three doses, with titration based on response. FDA Access Data+1
Class: Anticonvulsant / neuropathic pain agent.
Purpose: Similar to gabapentin, to help constant burning or stabbing pain that interferes with sleep and activity.
Mechanism: Like gabapentin, it binds to α2δ calcium channel subunits and reduces abnormal electrical firing in pain fibers, lowering pain messages sent to the brain. FDA Access Data+1
Common side effects: Dizziness, drowsiness, blurred vision, weight gain and ankle swelling; careful monitoring is needed in people with balance problems. FDA Access Data+1
3. Duloxetine
Duloxetine (Cymbalta) is an antidepressant approved by the FDA for diabetic peripheral neuropathic pain, fibromyalgia and major depression. Adult doses for neuropathic pain often range around 60 mg once daily. ScienceDirect+1
Class: Serotonin-noradrenaline reuptake inhibitor (SNRI).
Purpose: To reduce neuropathic pain and at the same time help with low mood or anxiety, which are common in chronic illness.
Mechanism: By increasing serotonin and noradrenaline levels in the spinal cord and brain, duloxetine strengthens natural “descending” pain control pathways that dampen pain signals. ScienceDirect+1
Common side effects: Nausea, dry mouth, sweating, sleep problems and sometimes increased blood pressure; it must not be stopped suddenly. FDA Access Data+1
4. Amitriptyline
Amitriptyline is an older antidepressant that is widely used in low doses for chronic nerve pain. The FDA label shows use for depression, but pain control is an established off-label use; doses for pain are typically much lower (for example 10–75 mg at night for adults). FDA Access Data+1
Class: Tricyclic antidepressant (TCA).
Purpose: Night-time dosing can improve sleep and reduce burning or electric-shock like pain that worsens in the evening.
Mechanism: It blocks reuptake of serotonin and noradrenaline and also calms pain fibers through sodium channel effects, lowering pain transmission in the spinal cord. FDA Access Data+1
Common side effects: Dry mouth, constipation, blurry vision, weight gain and morning grogginess; it can affect heart rhythm, so it is not right for everyone. FDA Access Data+1
5. Venlafaxine extended-release
Venlafaxine XR (Effexor XR) is an SNRI antidepressant sometimes used off-label for neuropathic pain when duloxetine is not tolerated. Adult doses often start around 75 mg daily and can be increased gradually. FDA Access Data+1
Class: SNRI antidepressant.
Purpose: To manage combined symptoms of pain, anxiety and depression in chronic neuropathy.
Mechanism: Like duloxetine, it enhances descending inhibitory pain pathways by boosting serotonin and noradrenaline in central nervous system synapses. FDA Access Data+1
Common side effects: Nausea, increased blood pressure, sweating, trouble sleeping or withdrawal symptoms if stopped too quickly. FDA Access Data+1
6. Carbamazepine
Carbamazepine is an anticonvulsant licensed for trigeminal neuralgia and seizures. Some neurologists may use it cautiously for sharp, stabbing neuropathic pain. Adult doses are usually titrated from low levels (for example 100–200 mg/day) upward. Orpha.net+1
Class: Sodium-channel blocking anticonvulsant.
Purpose: To control short, electric-shock-like pain bursts.
Mechanism: Carbamazepine stabilizes overactive sodium channels in nerve membranes, reducing abnormal firing that causes sudden pain spikes. Orpha.net+1
Common side effects: Drowsiness, dizziness, low sodium, liver and blood count changes; it needs blood test monitoring. Orpha.net+1
7. Oxcarbazepine
Oxcarbazepine is related to carbamazepine and is sometimes tried for neuropathic pain with possibly fewer drug interactions. Adult doses are titrated slowly according to the FDA label. FDA Access Data+1
Class: Anticonvulsant.
Purpose: Similar to carbamazepine, for sharp nerve pains not controlled by first-line agents.
Mechanism: It also blocks voltage-gated sodium channels in neurons, stabilizing hyperexcitable membranes and diminishing pain impulses. FDA Access Data+1
Common side effects: Dizziness, fatigue, low sodium and allergic skin reactions in some people. FDA Access Data+1
8. Topical lidocaine patches
Lidocaine 5 % patches are approved for post-herpetic neuralgia and sometimes applied to localized painful areas in peripheral neuropathy. The patch is usually worn up to 12 hours in 24 hours on intact skin. MalaCards+1
Class: Local anesthetic.
Purpose: To numb highly sensitive spots (for example, the top of the foot) without affecting the whole body.
Mechanism: Lidocaine blocks sodium channels in local nerve endings so that pain signals do not start or reach the brain. MalaCards+1
Common side effects: Local skin irritation or redness; systemic side effects are rare when used correctly. MalaCards+1
9. High-strength capsaicin patch (8 %)
Capsaicin 8 % patch is FDA-approved for certain peripheral neuropathic pain conditions. It is applied in clinic for a short time and can give long-lasting relief in some people. nhs.uk+1
Class: Topical TRPV1 receptor agonist.
Purpose: To reduce intense burning in a limited area, such as the toes or dorsum of the foot.
Mechanism: Capsaicin overstimulates and then desensitizes pain fibers (C-fibers), leading to reduced pain signal transmission for weeks or months. nhs.uk+1
Common side effects: Strong burning on application, redness and temporary increased pain; must be applied by trained professionals. nhs.uk+1
10. Tramadol
Tramadol is an opioid-like analgesic with additional serotonin and noradrenaline reuptake inhibition, used short-term for moderate to severe pain when other options are not enough. Adult doses are limited to reduce risks of dependence and side effects. FDA Access Data+1
Class: Weak opioid / SNRI-like analgesic.
Purpose: To provide rescue pain relief in severe neuropathic pain “flare-ups.”
Mechanism: Tramadol acts on μ-opioid receptors and inhibits reuptake of serotonin and noradrenaline, enhancing descending pain control pathways. FDA Access Data+1
Common side effects: Nausea, dizziness, constipation, sleepiness, and risk of dependence or withdrawal; risk of seizures at high doses or with some antidepressants. FDA Access Data+1
11. NSAIDs (e.g., ibuprofen, naproxen)
Non-steroidal anti-inflammatory drugs are not very effective for pure nerve pain but can help joint and muscle pain from deformities, overuse or surgery. Doses follow usual over-the-counter or prescription guidance for adults. Cleveland Clinic+1
Class: Anti-inflammatory analgesics.
Purpose: To reduce musculoskeletal pain and inflammation around joints and soft tissues.
Mechanism: NSAIDs inhibit cyclo-oxygenase enzymes (COX-1 and/or COX-2) and reduce prostaglandin production, lowering inflammatory pain in tissues that support the feet and legs. Cleveland Clinic+1
Common side effects: Stomach upset, ulcers, kidney strain and higher blood pressure if used in large or long doses. MDPI
12. Baclofen
Baclofen is an anti-spasticity drug used when there is troublesome muscle stiffness or cramps. It is not specific for CMT but may help if tone is increased. ScienceDirect+1
Class: GABA-B receptor agonist.
Purpose: To ease cramps and muscle tightness that disturb sleep or walking.
Mechanism: Baclofen stimulates GABA-B receptors in the spinal cord, reducing the reflex activity that causes muscle spasm. ScienceDirect+1
Common side effects: Drowsiness, dizziness and weakness; sudden withdrawal can cause serious reactions, so dose changes must be slow. JMC Chemical Science
13. Tizanidine
Tizanidine is another muscle-relaxant sometimes used when baclofen is not suitable. It can reduce spasticity and painful muscle over-activity. ScienceDirect+1
Class: α2-adrenergic agonist.
Purpose: To reduce muscle tone and related pain.
Mechanism: It acts on α2 receptors in the central nervous system to decrease release of excitatory amino acids and calm spinal motor neurons. JMC Chemical Science
Common side effects: Low blood pressure, sleepiness and dry mouth; liver function sometimes needs monitoring. JMC Chemical Science
14. Low-dose clonazepam at night
Clonazepam is a benzodiazepine used for seizures and severe anxiety; some clinicians use very low doses at night for restless legs, myoclonus or anxiety linked to neuropathy. Because of dependence and sedation risks, it is used cautiously and usually short term. ScienceDirect+1
Class: Benzodiazepine.
Purpose: To reduce distressing jerks or severe night-time anxiety when other treatments fail.
Mechanism: It enhances GABA-A receptor activity, increasing inhibition in the central nervous system and calming muscle and nerve overactivity. JMC Chemical Science
Common side effects: Drowsiness, memory problems, dependence and withdrawal; not a first-line option and must be carefully supervised. JMC Chemical Science
15–20. Other individualized medicines
Depending on the person, doctors may also consider: topical diclofenac gel for localized joint pain, low-dose antidepressants beyond duloxetine and amitriptyline, medications for sleep, or treatment of associated conditions like depression or anxiety. All of these rely on existing FDA labels for those conditions, and in CMT they are chosen case-by-case. ScienceDirect+2Mayo Clinic+2
Because you are a teenager, your neurologist and family doctor must decide if any of these are appropriate for you. Never start these drugs on your own from online information.
Dietary Molecular Supplements
There is no supplement proven to cure or stop CMT2T, and evidence even for general CMT is limited. Most data come from studies in diabetic neuropathy or other nerve injuries. Supplements should only be added after your doctor checks for interactions and correct doses.
1. Alpha-lipoic acid (ALA)
Alpha-lipoic acid is an antioxidant studied mainly in diabetic peripheral neuropathy; several trials show modest improvement in pain and nerve function at doses such as 600 mg/day for adults. PubMed+2ClinicalTrials.gov+2
Typical adult dose used in studies: 300–600 mg once or twice daily (your doctor must decide).
Function: Acts as a powerful antioxidant and co-factor in mitochondrial energy reactions.
Mechanism: ALA may reduce oxidative stress and improve blood flow in nerves, possibly improving nerve conduction and reducing pain; however, clear evidence for CMT is lacking. MDPI+2Cureus+2
2. Acetyl-L-carnitine (ALC)
ALC has been studied in chemotherapy-induced and HIV-related painful neuropathies, where it showed moderate benefit in reducing pain and supporting nerve regeneration. PMC+2PLOS+2
Dose in trials: Often 1–3 g per day in divided doses.
Function: Helps transport fatty acids into mitochondria for energy and may support nerve repair.
Mechanism: ALC appears to improve mitochondrial function and may enhance nerve fiber regeneration and myelin repair, but strong data in CMT are still missing. PLOS+1
3. Omega-3 fatty acids (EPA/DHA)
Omega-3 polyunsaturated fatty acids, found in fish oil, play a role in nerve cell membranes. Animal studies show they can reduce inflammation and support nerve regeneration after injury, although human trials in peripheral neuropathy show mixed results. Understanding Animal Research+3PMC+3Frontiers+3
Typical dose: 1–3 g/day combined EPA+DHA in adults, adjusted by clinicians.
Function: Anti-inflammatory and membrane-stabilizing lipids.
Mechanism: Omega-3s are incorporated into nerve cell membranes, reduce inflammatory mediators and may support remyelination and axon repair; evidence for CMT2T is not yet strong. PMC+2Frontiers+2
4. Vitamin D (cholecalciferol)
Vitamin D deficiency is common worldwide and has been linked with worse neuropathic pain and poorer nerve health in several conditions. Supplementation in deficient people may reduce pain and improve function. OmegaQuant+3PMC+3Frontiers+3
Typical adult dose: Often 600–2000 IU/day; high doses only under medical supervision.
Function: Regulates calcium balance, bone health, muscle function and immune response.
Mechanism: Adequate vitamin D may support nerve growth factor expression, maintain healthy muscle and bone and possibly reduce neuropathic pain; but it does not directly treat the genetic cause of CMT2T. Frontiers+2ScienceDirect+2
5. B-complex vitamins (B1, B6, B12)
B vitamins are essential for nerve function. Deficiency of B12 or B1 can itself cause neuropathy, so correcting low levels is important. ScienceDirect+1
Dose: Depends on blood levels and medical guidance; sometimes high-dose B12 injections are used in deficiency.
Function: Support myelin formation, energy metabolism and neurotransmitter production.
Mechanism: Restoring normal vitamin levels helps nerves maintain their myelin coating and proper electrical conduction; this is supportive care, not a cure for CMT2T mutations. ScienceDirect+1
6. Coenzyme Q10 (CoQ10)
CoQ10 is part of mitochondrial energy production and has antioxidant properties. It has been explored in some mitochondrial and neuromuscular disorders with varying results. MDPI+1
Dose: Often 100–300 mg/day in adults, under medical advice.
Function: Supports mitochondrial ATP production and reduces oxidative stress.
Mechanism: By improving mitochondrial efficiency, CoQ10 may help energy-hungry nerve cells, but strong evidence in CMT2T specifically is not yet available. MDPI+1
7. Magnesium
Magnesium is important for nerve conduction and muscle relaxation. Low magnesium can worsen cramps and neuromuscular excitability. JMC Chemical Science+1
Dose: Usually within standard recommended dietary allowances unless deficiency is proven.
Function: Acts as a co-factor in many enzymatic reactions and stabilizes nerve membranes.
Mechanism: Correct magnesium levels may lower over-excitability in peripheral nerves and muscles, reducing cramps, although data in CMT are limited. JMC Chemical Science+1
8. Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant effects and is being studied in various chronic inflammatory and neurodegenerative conditions. MDPI+1
Dose: Varies widely; many supplements use 500–1500 mg/day with absorption enhancers.
Function: Reduces inflammatory signaling molecules (cytokines) and oxidative damage.
Mechanism: By lowering inflammation and oxidative stress, curcumin may provide supportive benefits to peripheral nerves, but clinical data in CMT are not yet strong. MDPI+1
9. N-acetylcysteine (NAC)
NAC is a precursor to glutathione, a key antioxidant in cells. It is used medically as a mucolytic and in paracetamol (acetaminophen) overdose. In research, NAC has been explored as a neuroprotective agent. MDPI+1
Dose: Only under medical supervision; not for self-prescription.
Function: Replenishes glutathione and counters oxidative stress.
Mechanism: By boosting antioxidant defenses, NAC may protect nerves from secondary damage, though this has not been proven in CMT2T. MDPI+1
10. Polyphenol-rich foods or extracts (e.g., green tea, berries)
Rather than pills, many experts suggest eating polyphenol-rich foods that contain natural antioxidants. These foods support general vascular and nerve health. MDPI+1
Dose: As part of a balanced diet rather than high-dose supplements.
Function: Provide antioxidants and anti-inflammatory compounds.
Mechanism: Polyphenols can reduce oxidative stress and may support micro-circulation to nerves, but they do not change the underlying gene mutation. MDPI+1
Immunity-Boosting, Regenerative and Stem-Cell-Related Drugs
There are no approved regenerative or stem-cell drugs for CMT2T. Current work is mostly in research trials for other CMT types or in animal models. These approaches should only be considered inside properly regulated clinical trials.
1. Neurotrophin-3 (NT-3) AAV gene therapy (AAV1.NT-3)
Gene therapy delivering the NT-3 gene using an adeno-associated virus (AAV) vector has shown disease-modifying effects in mouse models of CMT2D and is being studied in CMT1A. ScienceDirect+2OUP Academic+2
Dose: Experimental; dosing regimens are defined only in clinical protocols.
Function: Aims to promote nerve regeneration and remyelination by increasing NT-3 levels.
Mechanism: NT-3 supports survival and regrowth of sensory and motor neurons; gene therapy provides long-term local expression, improving myelination and neuromuscular junction function in animal models. It is not yet available for routine CMT2T care. ScienceDirect+1
2. PXT3003 (triple-combination oral therapy)
PXT3003 combines baclofen, naltrexone and sorbitol in low doses; it has been in phase III trials for CMT1A with mixed results and ongoing regulatory discussion. Truffle Capital+3ClinicalTrials.gov+3Clinical Trials Register+3
Dose: Only defined within clinical trials; not an approved standard treatment.
Function: Attempts to reduce over-expression of PMP22 and improve myelination in CMT1A.
Mechanism: The combination may modulate GABA-B, opioid and metabolic pathways to normalize PMP22 protein levels in Schwann cells, thereby stabilizing myelin. It is not specific for CMT2T and is still investigational. PMC+1
3. Mesenchymal stem-cell therapy (e.g., EN001)
A phase 1b/2a trial is exploring EN001, a mesenchymal stem-cell product designed to release regenerative factors and promote remyelination in CMT1A. Charcot-Marie-Tooth Association+2StemSave+2
Dose: Defined only in trial protocols.
Function: To deliver cells that secrete growth factors and immune-modulating substances around damaged nerves.
Mechanism: Mesenchymal stem cells may home to injured nerves, release trophic factors and reduce inflammation, supporting remyelination. At present this remains experimental and not standard for CMT2T. PMC+1
4. Autologous stem-cell procedures (case reports)
There are isolated reports of private “stem-cell procedures” being used in CMT, but evidence is limited to case reports and not controlled trials. PMC+2Wiley Online Library+2
Dose: Highly variable; often not standardized.
Function: Claims to boost regeneration by re-injecting a person’s own processed stem cells.
Mechanism: Theoretical stimulation of repair pathways; however, safety, dosing and true benefit are not well established, and these procedures can be expensive and risky outside regulated trials. PMC+1
5. Other gene-replacement approaches for CMT subtypes
Reviews describe several AAV and non-viral gene therapies in preclinical or early clinical stages for different CMT forms (e.g., CMT2S, CMT4C). These studies show that gene replacement or silencing strategies can improve nerve function in animal models. PMC+2Institut de Myologie+2
Dose: Only in research settings.
Function: To correct or silence the faulty gene, addressing the root cause.
Mechanism: Depending on the subtype, therapies may add a healthy gene copy, silence an over-active gene or edit DNA. No such therapy is yet available for routine CMT2T treatment. Institut de Myologie+1
6. Immune-supportive vaccines and infection control
While not regenerative drugs, routine vaccines (influenza, pneumonia, COVID-19) and infection prevention indirectly protect people with CMT2T by reducing serious illnesses that can worsen weakness and mobility. Mayo Clinic+1
Dose: According to national immunization schedules.
Function: To boost immune protection against infections that could lead to hospital stays and deconditioning.
Mechanism: Vaccines train the immune system to recognize pathogens quickly; this helps avoid prolonged illnesses that can worsen nerve function through inactivity and metabolic stress. JMC Chemical Science+1
Surgical Treatments (Procedures and Why They Are Done)
Surgery in CMT2T does not repair the nerve damage, but it can correct deformities that make walking painful or unsafe.
1. Foot tendon transfer surgery
Tendon transfer moves a working tendon (for example tibialis posterior) to replace a weak muscle that lifts the foot. In CMT cavovarus deformity, tendon transfers can correct foot drop and rebalance the foot. Wikipedia+3www.elsevier.com+3Lippincott Journals+3
Why it is done: To improve foot position, reduce tripping and sometimes allow lighter bracing or no brace.
2. Osteotomy (bone realignment) for cavus foot
Osteotomy involves cutting and reshaping bones of the midfoot or heel to correct high arches and twisted alignment. Studies show that such surgery can improve foot shape, walking and quality of life in CMT. PubMed+3PubMed+3Journal of the Foot & Ankle+3
Why it is done: To create a more plantigrade (flat on the floor), stable foot that fits in shoes and braces better and reduces pain.
3. Plantar fascia release and soft-tissue lengthening
Tight plantar fascia and calf tendons contribute to deformity. Surgical release or lengthening of these tissues helps the foot straighten and may be combined with osteotomy and tendon transfers. www.elsevier.com+1
Why it is done: To free the foot from tight soft tissues so bones can be placed in a better alignment and movement is less painful.
4. Joint fusion (arthrodesis) in severe deformities
In very rigid, painful deformities, fusing certain joints (such as triple arthrodesis) can stabilize the foot. This sacrifices some motion but can provide a solid base for walking. www.elsevier.com+2ENMC+2
Why it is done: To relieve chronic pain and instability when softer reconstructive options are not enough.
5. Upper-limb tendon surgery for hand function (selected cases)
In people with severe hand weakness, tendon transfer procedures in the upper limb can sometimes improve pinch, grasp or wrist position. PubMed+2ScienceDirect+2
Why it is done: To allow better grip and independence in self-care when non-surgical measures fail.
Surgery should always be a shared decision between you, your family and experienced orthopedic and neuromuscular teams after careful discussion of risks, benefits and realistic goals. PubMed+2NMD Journal+2
Prevention Strategies
You cannot prevent being born with CMT2T, but you can help prevent complications and slow secondary damage:
Protect your feet every day – check for blisters, cuts and redness, use proper shoes and socks, and see a podiatrist regularly. Mayo Clinic+1
Stretch and move daily per your physiotherapist’s plan to prevent contractures and stiffness. nhs.uk+1
Use braces, splints and walking aids as advised instead of avoiding them because of appearance; they protect you from falls. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Disease+2
Avoid clearly neurotoxic drugs when possible, especially vincristine and some chemotherapy drugs, and always tell doctors you have CMT before new treatments. Wikipedia+4Charcot-Marie-Tooth Association+4Charcot-Marie-Tooth Disease+4
Maintain a healthy weight with balanced nutrition to reduce stress on joints and muscles. Mayo Clinic+1
Do gentle, regular exercise to keep your heart, lungs and remaining muscles strong. nhs.uk+2Charcot-Marie-Tooth Disease+2
Avoid smoking and second-hand smoke to protect blood flow to nerves and overall health. JMC Chemical Science+1
Treat vitamin deficiencies (especially vitamin D and B12) if blood tests show problems, under medical supervision. Frontiers+2ScienceDirect+2
Get recommended vaccines to reduce severe infections that could cause long bed rest and deconditioning. JMC Chemical Science+1
Keep regular follow-up at a neuromuscular clinic so new problems are picked up early and treated before they become severe. ScienceDirect+2PMC+2
When to See a Doctor Urgently
You should seek medical help (and tell your parents/guardians) if you notice any of the following:
Sudden worsening of weakness or walking, especially if you cannot lift your feet at all or keep falling. Mayo Clinic+1
New, severe or rapidly spreading pain, burning or numbness that is different from your usual symptoms. Mayo Clinic+1
Open sores, ulcers or infections on your feet or legs, especially if you cannot feel them well. Mayo Clinic+1
Signs of breathing, swallowing or speech problems, such as shortness of breath lying flat, choking on food or a weak cough. Mayo Clinic+1
Serious side effects from medicines, like extreme drowsiness, confusion, rash, yellow eyes, severe stomach pain, very low mood or thoughts of self-harm (in that case, seek emergency help immediately and tell a trusted adult). JMC Chemical Science+2FDA Access Data+2
Before starting any chemotherapy or new strong medicine, to check whether it could harm your nerves. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Disease+2
Routine check-ups with your neurologist should also happen at intervals they recommend, even if you feel stable, to keep your care plan updated. ScienceDirect+1
What to Eat and What to Avoid
Because CMT2T is genetic, diet cannot cure it, but a healthy eating pattern supports nerves, muscles and general health.
Eat plenty of colorful vegetables and fruits – they provide vitamins, minerals and antioxidants that support blood vessels and nerves. MDPI+1
Choose whole grains (brown rice, whole-wheat bread, oats) instead of refined grains to keep energy stable and support a healthy weight. JMC Chemical Science+1
Include lean protein like fish, eggs, beans, lentils and skinless poultry to support muscle repair and strength. JMC Chemical Science+1
Use healthy fats, especially sources of omega-3 (small oily fish such as sardines, mackerel, hilsa), nuts and seeds, in moderation. PMC+2Frontiers+2
Take enough vitamin D and calcium through food (fish, eggs, fortified milk) and safe sunlight exposure, or supplements if your doctor advises. Frontiers+2ScienceDirect+2
Limit sugary drinks and sweets, which add calories without nutrition and can worsen weight and metabolic health. JMC Chemical Science+1
Avoid very high doses of any supplement without supervision, as too much vitamin D, B6 or others can actually damage nerves. JMC Chemical Science+1
Reduce very salty, greasy fast-foods that increase heart and kidney strain and may worsen swelling. JMC Chemical Science+1
Avoid alcohol or keep it minimal, as alcohol itself can be toxic to nerves and worsen neuropathy; as a minor you should not drink alcohol at all. JMC Chemical Science+1
Drink enough water and include fiber-rich foods (vegetables, fruits, whole grains) to reduce constipation, which can be worsened by some pain medicines. JMC Chemical Science+1
Frequently Asked Questions
1. Can Charcot-Marie-Tooth disease type 2T be cured?
At present there is no cure for CMT2T. Treatment focuses on managing symptoms, protecting joints and nerves, and maintaining independence. Research in gene therapy and stem-cell approaches is active but still in trial stages and not yet standard care. Institut de Myologie+3ScienceDirect+3Genomics Education Programme+3
2. Will I end up in a wheelchair?
Many people with CMT live their whole lives walking with braces or other aids; some will need a wheelchair for long distances or later in life. The course varies greatly between people, even in the same family. Early physiotherapy, bracing, and good foot care can help you stay mobile for longer. ScienceDirect+3Mayo Clinic+3PMC+3
3. Does exercise make CMT2T worse?
Gentle, well-planned exercise usually helps more than it harms. Over-strenuous or high-impact exercise can cause injuries, but supervised stretching, strengthening and aerobic activity are recommended to prevent contractures and maintain fitness. Pod NMD+3nhs.uk+3Physiopedia+3
4. Is it safe to have children if I have CMT2T?
CMT2T is genetic, so there is a chance of passing it to children. Genetic counselling can explain the inheritance pattern for your specific mutation and discuss options such as testing or assisted reproductive techniques where available. FlyBase+2Mayo Clinic+2
5. What medicines should I avoid?
The main clearly dangerous medicine is the chemotherapy drug vincristine, which can cause severe, sometimes irreversible neuropathy in people with CMT and is generally contraindicated. Other potentially neurotoxic medicines (some chemotherapy agents, high-dose metronidazole, some antivirals and others) should be used only with great caution. Always tell any doctor that you have CMT before starting new medicines. Wikipedia+5Charcot-Marie-Tooth Association+5Charcot-Marie-Tooth Disease+5
6. How is CMT2T different from other CMT types?
CMT2T is an axonal form linked to specific gene mutations, while other types affect the myelin sheath or different genes. All forms share slowly progressive weakness and sensory loss, but the age of onset, pattern of involvement and severity can differ. There is no major difference in symptomatic treatment principles between types. FlyBase+2Wikipedia+2
7. Will surgery fix my CMT2T?
Surgery cannot fix the gene problem or nerve damage, but it can correct foot deformities, reduce pain and improve walking. It is usually considered when bracing and therapy are not enough and deformities cause big problems. Mayo Clinic+4PubMed+4www.elsevier.com+4
8. Are stem-cell treatments from private clinics a good idea?
At the moment, evidence for private stem-cell procedures is very limited and they can be costly and risky. True stem-cell therapies for CMT are still in controlled clinical trials and not approved for routine use. You should be very cautious about any clinic promising a “cure.” StemSave+3Wiley Online Library+3PMC+3
9. Can diet alone treat my CMT2T?
No diet can cure CMT2T, but healthy eating supports muscles, bones and general health, making it easier to cope with the disease. Supplements such as alpha-lipoic acid or omega-3s may help neuropathic pain in other conditions, but evidence in CMT is still weak and they should never replace standard care. Cochrane+4PubMed+4PLOS+4
10. Is CMT2T life-threatening?
CMT is usually not directly life-shortening, but severe weakness, foot deformities, falls, or breathing problems can cause complications that affect health and quality of life. Good long-term care and prevention of complications are very important. Wikipedia+2Mayo Clinic+2
11. Should I have genetic testing?
Genetic testing can confirm the diagnosis and identify the exact gene change, such as those associated with CMT2T. This can guide family counselling and, in the future, may guide targeted therapies. Testing is usually arranged by a neurologist or geneticist with pre- and post-test counselling. FlyBase+2Mayo Clinic+2
12. Can I play sports?
Many people with CMT can take part in low-impact sports, like swimming or cycling, with proper support. Contact sports or high-impact activities that involve jumping and sudden direction changes may increase injury risk. Your physiotherapist can help choose safe options. nhs.uk+2Charcot-Marie-Tooth Disease+2
13. Will physiotherapy be needed forever?
Because CMT2T is lifelong and slowly progressive, physiotherapy is usually an ongoing part of management. The exact intensity may change over time, with more focus on maintaining function rather than big strength gains. PMC+2nhs.uk+2
14. Do braces mean my disease is getting worse?
Needing braces or walking aids does not mean you have “failed.” Instead, they are tools to help you stay active and safe. Early use can actually delay complications and keep you independent for longer. Hancock Health+3Charcot-Marie-Tooth Association+3Charcot-Marie-Tooth Disease+3
15. What is the most important thing I can do right now?
The most important steps are: work closely with a neuromuscular specialist, follow a physiotherapy and orthotic plan, protect your feet, avoid neurotoxic medicines, eat healthily, and look after your mental health. These actions cannot cure CMT2T, but they greatly improve daily life and long-term outcomes. PMC+2ScienceDirect+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 29, 2025.
